Dr. Antonios Douros received his MD in 2009 and his Dr. med. (Doctorate Degree) in 2012, and was trained in clinical pharmacology from 2012 to 2016 at Charité – Universitätsmedizin Berlin in Berlin, Germany. He completed a post-doctoral fellowship in pharmacoepidemiology from 2016 to 2018 at the Department of Epidemiology, Biostatistics and Occupational Health, McGill University. He then joined the Department of Medicine as an Assistant Professor in 2019. Dr. Douros studies the effectiveness and safety of commonly prescribed medications in vulnerable populations, including patients with liver disease, older adults, as well as patients subjected to polypharmacy and at risk of drug-drug interactions. Given the underrepresentation of such populations in randomized trials, this research program provides much needed information regarding the benefit-risk profile of drugs. For the implementation of this program, Dr. Douros applies his experience with observational studies using large electronic healthcare databases and his knowledge with respect to the distinct pharmacologic features of vulnerable populations. Dr. Douros has received a personal salary award from the German Research Foundation and research grants from the Canadian Institutes of Health Research.
pharmacoepidemiology; clinical pharmacology
drug-drug interactions; vulnerable populations